CareSignal deviceless remote patient monitoring engages large patient populations via evidence-based automated texts messages or phone calls, identifying patients with worsening symptoms and alerting case managers and providers of opportunities for proactive care. With 13+ peer reviewed journal publications and industry leading engagement rates, CareSignal decreases unnecessary medical cost, facilitates right site of services, and improves health for thousands of patients a day. CareSignal has been successfully implemented in healthcare organizations across the country, including self-insured employers, payers, and health systems, with outcomes such as an average 2% HbA1c decrease per patient and $200 decrease PMPM.

CareSignal provides an accessible remote patient monitoring platform that improves payer and provider performance in value-based care by engaging and identifying rising-risk patients. Care teams receive real-time alerts enabling real-time prioritization and outreach, and patients respond to evidence-based questions via text messages or phone calls. 

AccendoWave - the only company that can remotely monitor pain. Pain is the #1 reason for a hospital readmit.

A Health Equity Solution - AccendoWave Benchmarks Pain Data with Machine Learning Technology. AccendoWave does real-time objective individual assessment of patient pain. For use with telemedicine (as you see only have the patient and loose all the non verbal pain cues), Hospital at Home, Home Care, Clinic or Urgent Care site.

AccendoWave utilizes full spectrum brain analysis and deep learning algorithms to objectively measure pain. We have the largest Global Real-Time Benchmarked Pain Database. 

Health care has a pain bias problem. Pain is one of the most subjective measures in all of medicine - and thus subject to bias. There is an extensive body of research that shows bias: women and pain, ethnicity and pain, and seniors and pain. For many in these groups - their #1 complaint is that their pain isn't believed. An unbiased medical technology which can validate patient pain is critical given Provider Health Equity pledges.

Individual patient pain can be validated and compared to a pain database for use with pain care pathways. 

AccendoWave, a Pain Data Company with machine learning pain measurement & management technology. 

AccendoWave, a Top 4 Global Best in Class Health Equity Solution and Top 15 Global Best in Class Remote Monitoring Company, benchmarks pain data (specialty, gender, age) with machine learning technology to eliminate bias, improve outcomes and reduce health care costs. Incubated by HCA (188 Hospitals & 5-6% US Inpatient Care) - Samsung and AT&T are our partners.

AccendoWave has nine objective benchmarked pain databases (Women, Oncology, Maternal Health, Emergency Room, MSK, Med/Surg, ICU, Seniors, Adults). 

Pain is the primary reason patients access healthcare - so pain is a primary driver of health care cost. Pain levels don't show up in claims data nor can objective pain levels be extracted from EHR's. So Employers/Health Plans/Hospitals/Government have no visibility into or data on the primary driver of health care costs.  

Pain has a bias problem. There is extensive research & RWD showing bias: women and pain, ethnicity and pain, seniors and pain. 

The real world data from our health care systems is crushinly similar. #1 complaint of patients of color is that their pain isn't believed. This results in less pain medicine given to these patients and later stage cancer diagnosis.  

Given the new state, health plan and CMS initiatives on health equity, and the recent massive (150 - 250M) hospital pain lawsuits, health systems must utilize objectve pain data and focus on this pain bias problem. 

Additionally, a patient whose pain isn't believed doesn't trust their provider or health care system, and their patient experience is a zero. 

AccendoWave provides objective benchmarked pain data and insights to eliminate pain bias, improve care and reduce stakeholder healthcare costs. 

AccendoWave utilizes full spectrum brain analysis and deep learning algorithms to measure & monitor discomfort/pain. AccendoWave has four products: 

1. Digital Opioid Alternative (Hospital & Home) Value Proposition - Reduce Opioid Usage, Reduce Length of Stay, and Improve Patient Satisfaction. Most Cost Effective Choice to Meet The Joint Commission Non Pharma Pain Treatment Modality Requirement. Home - to reduce opioid usage in the transition from hospital to home. *AT&T reimburses for AccendoWave for 30 days post hospital discharge. 

2. UV Sanitizing & Charging Technology (Hospital) Value Proposition - Infection Control and Simplified Charging for AccendoWave Hospital Technology. 

3. Top 15 Global Best in Class Remote Pain Monitoring Technology. Value Proposition - Objective Data Insights into Pain - A Primary Driver of Cost & Outcomes. *AT&T reimburses for AccendoWave for 30 days post hospital discharge. 

4. Largest Global Real-Time Database on Pain with Nine Separate Objective Pain Databases. Value Proposition - Objective Pain Benchmarked Data to Address Health Equity, Improve Operational Performance, Reduce Pain Lawsuit Risk, Reduce Costs, Improve Patient Satisfaction, and Demonstrate Outcomes. 

Because CareSignal does not require any downloads, apps, passwords, or logins, it requires the least activation energy possible from the patient, which directly ties to high engagement and thus outcomes. CareSignal eliminates barriers to engagement with remote patient monitoring programs, including financial resources to have access to stable WiFi or the ability to purchase a smart phone to download an app. All a patient requires to participate in CareSignal programs is access to a phone, which makes the programs incredibility easy to use from the patient perspective that has led to high engagement rates and significant clinical and financial outcomes.

CareSignal has several key differentiators from existing products and competitors:

1)Proven clinical and financial outcomes, reduction in unnecessary utilization and hospitalizations:

13+ peer-reviewed, positive outcome research publications that give evidence to CareSignal programs both clinically and financially. Further, there are several white papers, case studies & ROI claims analyses outlining cost savings for current partners. A recent claims analysis with a current health system partner demonstrated $32M in medical cost reduction with 30k patients over 4 years. 

2)Deviceless RPM is Scalable:

Engage and monitor tens of thousands of high and rising-risk patients within weeks. Care teams can manage 15x the number of patients with the same amount of staff; a particularly important feature when healthcare budgets & personnel are under strain and the need to create sustainable, scalable proactive care models is essential for growth and success in value-based care. Case manager caseloads increase from 1:100 to 1:1,500 while maintaining high staff and patient satisfaction.

Because the programs are deviceless, activation takes minutes with tens of thousands of patients for a longer engagement period. The tech support, logistics, WiFi, and financial resources required for devices and apps are the barriers realized that prevent even the possibility of a scalable solution.

3)Accessible Technology for Long-Term Engagement and Data Collection: 

CareSignal programs allow patients to use their current phone (no downloads, no passwords, no searching required) & patients never pay for CareSignal messages, no WiFi needed, data or minutes. CareSignal programs directly address health inequities that are often exacerbated by device or app based RPM that further the digital divide.

Due to the accessibility of CareSignal programs and ease of use, the programs have 6x greater engagement than health apps and 1 in 2 patients stay engaged for 12 months+.

Longer engagement means care teams collect more data on their patients, making them able to track their patients’ progress and monitor them for longer than other remote monitoring tools. Value-based care health systems required long-term RPM programs as chronic conditions unfortunately do not last 30 days, but a life time of support, self-manage, and staying connected to their care team. CareSignal programs are designed for patients to be engaged for years at a time to support patients to better self-manage their health at home, while staying connected to their care team if they have real-time worsening symptoms.

CareSignal AI, a proprietary combination of artificial intelligence and machine learning models, powers the superior activation, engagement, and retention that allow CareSignal to generate maximum value for our partners, and their patients. By predicting which patients are likely to disengage, CareSignal AI informs preventative re-engagement, up to ten times more effective than reactive outreach. And by helping target the right patients for activation, CareSignal AI drives better, more efficient adoption, even in challenging populations.

4)High Patient Satisfaction--Easy to use and Convenient:

CareSignal’s deviceless remote patient monitoring technology is accessible and free to all users. Patients receive the programs via automated texts or calls to whichever phone they currently use, including smartphones, landlines or basic mobile phones. 

We are the only company offering free-to-end-user text messages, meaning that patients engaged with the programs NEVER pay for messages or co-pay fees associated with device RPM. 

All messages are written at or below a 6th grade reading level and programs are available in both English and Spanish with other languages available. 

Patients on CareSignal reported high satisfaction with the level of care from their provider (8.4/9), and the level of communication (7.3/9). CareSignal programs are white labeled under the brand of our partners, where patients perceive the programs as their doctor calling them every day to monitor their health and care for them at home. 

5) Scale, Sustain, and Advance Care Management to Worker Smarter, Not Harder:

CareSignal does the heavy lifting for care management teams. Instead of care teams outreaching to patients at random, CareSignal condition specific programs collect patient biometric data and symptomatology data to automatically triage patients so care teams know in real-time which patients have crossed a critical threshold (ex: hypertensive episode) and which patients are experiencing worsening symptoms. 

The speed of implementation and ability to scale CareSignal programs is unmatched in the industry. Patient engagement specialists enroll and activate 1,000+patients/week, allowing case managers to manage 15x more patients at a time and operate top of license to do what they do best: care for more patients. As opposed to manual outbound phone calls and spending their time persuading patients to use a device or download an app while providing on-going tech support to patients, CareSignal eliminates this inefficient workflow to create a data informed case management model. With real-time risk stratification for large patient populations, CareSignal focuses the time and energy of case managers to focus on the right patients at the right time. 

6) Comprehensive Portfolio To Facilitate Comprehensive, Individualized Care for Every Patient:

At present, CareSignal has 30+ disease-specific programs, including chronic heart failure, COPD, diabetes, hypertension, and behavioral health programs for patients. CareSignal collects biometric and symptomatology data that allows one solution to facilitate a comprehensive, tailored approach to patient health and address chronic conditions, behavioral health, SDoH, transitions of care, and gaps in care. Because patients often have more than one chronic condition to manage, the CareSignal portfolio is designed for patients to participate in multiple programs simultaneously in order to support a comprehensive, holistic approach to care and address all areas of patient health.

Further, value-based care health systems have chosen CareSignal for 5 areas of strategic value:

1) Engagement:

-Increase access to care teams with accessible programs that do not require WiFi

-Increase in-network utilization, reduce churn

2) FTE optimization:

-Efficient, scalable, and sustainable case management model

3) Proactive, preventative care model:

-Facilitate meaningful interactions between patients and providers in between appointments 

-Mitigate risk with the ability to manage >50% of the population

4) Rare data collection and outcomes with large patient volumes

-Increase fee schedules and upside potential in payer contracts

5) Growth in value-based care

-Thrive in risk arrangements and increase market share

-Increase contracts for self-insured, MA, etc

AccendoWave is the only company that can remotely objectively measure individual patient pain. The technology can be used in the hospital and to remotely monitor and manage patient pain at home or in non acute care settings.

AccendoWave has the largest global database on pain and offers the only remote pain monitoring solution.